Related Experiment Video
Updated: Jan 17, 2026

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
Revolutionizing Diabetes Treatment with Insulin-loaded Nanoparticles
Jatin Vats1, Anjali Rana1, Ajesh Chauhan1
1Hindu College of Pharmacy, Sonipat, Haryana, India.
Insulin-loaded nanoparticles offer a promising solution for oral diabetes treatment. These nano-delivery systems enhance insulin stability and absorption, overcoming challenges with traditional injections.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Endocrinology
Background:
- Diabetes mellitus is characterized by high blood glucose, managed via subcutaneous insulin injections.
- Oral insulin delivery faces challenges due to gastric breakdown and low absorption rates.
- Nanotechnology offers a potential solution for protecting insulin and improving oral bioavailability.
Purpose of the Study:
- To review the utilization of insulin-loaded nanoparticles for advanced diabetes management.
- To evaluate the impact of nanoparticles on insulin stability, protection, and oral bioavailability.
- To analyze the therapeutic potential of nano-delivered insulin for diabetes treatment.
Main Methods:
- Literature review of studies on insulin-loaded nanoparticles.
- Analysis of research from databases like PubMed, Scopus, ScienceDirect, and Google Scholar.
- Evaluation of nanoparticle compositions (polymeric, lipid-based) and their preclinical outcomes.
Main Results:
- Insulin-loaded nanoparticles significantly improve insulin stability, bioavailability, and absorption.
- Polymeric and lipid-based nanoparticles show promising results in preclinical studies.
- Nano-delivery systems effectively overcome barriers to oral insulin administration.
Conclusions:
- Insulin-loaded nanoparticles represent a revolutionary approach to diabetes treatment.
- Nanotechnology enhances oral insulin delivery, offering a patient-friendly alternative.
- Further research and clinical studies are needed to validate large-scale application and feasibility.
Related Concept Videos
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

